Crossmark

Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling

Crossref DOI link: https://doi.org/10.1038/s41388-022-02256-3

Published Online: 2022-03-07

Published Print: 2022-04-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Komatsu, Masayuki https://orcid.org/0000-0003-1180-1746
Nakamura, Kanako https://orcid.org/0000-0002-2200-8359
Takeda, Takashi https://orcid.org/0000-0001-6686-5742
Chiwaki, Fumiko https://orcid.org/0000-0002-0914-9157
Banno, Kouji https://orcid.org/0000-0003-2610-2833
Aoki, Daisuke https://orcid.org/0000-0002-9596-8326
Takeshita, Fumitaka

Sasaki, Hiroki https://orcid.org/0000-0002-9443-0364
License Information

Text and Data Mining valid from 2022-03-07

Version of Record valid from 2022-03-07
More Information

Article History

Received: 29 January 2021

Revised: 8 February 2022

Accepted: 17 February 2022

First Online: 7 March 2022

Competing interests

: The authors declare no competing interests.